Simulect - direct healthcare professional communication (DHPC)

basiliximab

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC) : SIMULECT (basiliximab): Do not use WFI ampoules co-packed with vials of sterile freeze-dried powder of Simulect 10mg and 20mg

Key facts

• Medicine name:
  Simulect
• Active substance:
  basiliximab
• Therapeutic area (MeSH):
  • Graft Rejection
  • Kidney Transplantation
• Procedure number:
  EMEA/H/C/000207
• DHPC type:
  Quality defect
• Human ATC codes:
  L04AC02
• Dissemination date:
  21/04/2023